Noxopharm CEO talks Veyonda orphan drug designation from US FDA - Dr Gisela Mautner Chief Executive Officer and Managing Director, Noxopharm Ltd 00:00:00
Dr Gisela Mautner has more than 20 years of extensive leadership experience in global pharmaceutical organisations, including operational, medical and scientific advisory roles across multiple therapeutic areas. During her career she held senior positions at global pharmaceutical companies like MSD (Merck), Bayer and Amgen in Germany as well as Australia. She holds a Doctor of Medicine degree and a PhD from Germany, a Master of Public Health
